Company / Book Value per Share
Spyre Therapeutics, Inc. Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$11.87
FY2025
5-year range
$1.75 / $70.396
FY2021-FY2025
Trend
-17.3%
vs FY2024
Sector context
#48 of 209
Health Care
What the data says
Spyre Therapeutics, Inc.'s book value per share of $11.87 is higher than 77% of companies in the Health Care sector (FY2025). Book Value per Share has fluctuated over the past 10 years, ranging from $1.75 in FY2021 to $70.396 in FY2023.
Based on SEC 10-K filings.
$11.87 in FY2025 with a 5-year CAGR of +38.6%. Top quartile in the Health Care sector.
Declined from $70.396 to $11.87 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +61.2%
- 5-Year CAGR
- +38.6%
- 10-Year CAGR
- -
Sector benchmark
-93.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +38.6%, indicating consistent growth.
- In FY2025, book value per share decreased 17.3% year-over-year.
- Ranks #48 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.40 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.87 | -17.3% |
| FY2024 | $14.361 | -79.6% |
| FY2023 | $70.396 | +2384.7% |
| FY2022 | $2.833 | +61.9% |
| FY2021 | $1.75 | -24.5% |
| FY2020 | $2.318 | +11.2% |
| FY2019 | $2.085 | -44.8% |
| FY2018 | $3.777 | +13.5% |
| FY2017 | $3.327 | -48.3% |
| FY2016 | $6.431 | +117.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026